NCT03043521View on ClinicalTrials.gov

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 13, 2015

Primary Completion Date

August 12, 2015

Study Completion Date

August 12, 2015

Conditions
Healthy
Interventions
DRUG

Dexlansoprazole 60 MG

DRUG

CJ-12420 50mg

DRUG

CJ-12420 100mg

DRUG

CJ-12420 200mg

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT03043521 - Pharmacodynamic Properties of CJ-12420 on Evening Dosing | Biotech Hunter | Biotech Hunter